WallStreetZenWallStreetZen

NASDAQ: ALDX
Aldeyra Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ALDX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$37.5M
Current Profit Margin
0%

ALDX Return on Equity

Current Company
-29.4%
Current Industry
-63.5%
Current Market
188%
ALDX's Return on Equity (-29.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ALDX announces earnings.

ALDX Return on Assets

Current Company
-24.2%
Current Industry
2.9%
ALDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALDX Return on Capital Employed

Current Company
-28.14%
Current Industry
19.5%
ALDX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALDX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALDX$0.00-$35.21M-$37.54MN/AN/A
VSTM$0.00-$83.34M-$87.37M-100.00%N/A
CDT$0.00-$324.00k-$535.00kN/AN/A
PBYI$235.64M$47.52M$21.59M-1.25%N/A
QSI$1.08M-$90.40M-$95.96MN/AN/A
View Top Biotech Stocks

ALDX earnings dates

Next earnings date
May 2, 2024

Aldeyra Therapeutics Earnings & Revenue FAQ

What were ALDX's earnings last quarter?

On Invalid Date, Aldeyra Therapeutics (NASDAQ: ALDX) reported Q4 2023 earnings per share (EPS) of -$0.08, up 63.64% year over year. Total Aldeyra Therapeutics earnings for the quarter were -$4.75 million. In the same quarter last year, Aldeyra Therapeutics's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Aldeyra Therapeutics stock.

What was ALDX's earnings growth in the past year?

As of Q2 2024, Aldeyra Therapeutics's earnings has grown year over year. Aldeyra Therapeutics's earnings in the past year totalled -$37.54 million.

What is ALDX's earnings date?

Aldeyra Therapeutics's earnings date is Invalid Date. Add ALDX to your watchlist to be reminded of ALDX's next earnings announcement.

What was ALDX's revenue last quarter?

On Invalid Date, Aldeyra Therapeutics (NASDAQ: ALDX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aldeyra Therapeutics's revenue was $0.00.

What was ALDX's revenue growth in the past year?

As of Q2 2024, Aldeyra Therapeutics's revenue has grown null year over year. Aldeyra Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.